Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives

• Main Authors: Lawrence F. Eichenfield (Author), Jinan Liu (Author), Simran Marwaha (Author), James Piercy (Author), Daniel Sturm (Author), Peter Anderson (Author)
• Formato: Livro
• Publicado em: Adis, Springer Healthcare, 2024-03-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Introduction The 2021 US approval of ruxolitinib cream for treatment of atopic dermatitis (AD) in patients aged ≥ 12 years was based on the results of two pivotal phase 3 studies. Currently, real-world data to describe effectiveness of ruxolitinib cream and physician satisfaction with treat...